PRESS RELEASE published on 03/19/2026 at 18:30, 3 months 3 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
BRIEF published on 03/18/2026 at 18:05, 3 months 4 days ago Oxurion accuse réception de la notification de transparence d'Atlas Transparence Médicaments Oxurion Législation Belge Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 3 months 4 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities Transparence Financière Pharmaceutique Atlas Special Opportunities Investissements Digitaux Oxurion
BRIEF published on 03/18/2026 at 18:05, 3 months 4 days ago Oxurion Acknowledges Transparency Notification from Atlas Pharmaceuticals Transparency Oxurion Belgian Legislation Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 3 months 4 days ago Oxurion receives a transparency notification from Atlas Special Opportunities Pharmaceutical Financial Transparency Atlas Special Opportunities Oxurion Digital Investments
PRESS RELEASE published on 03/18/2026 at 18:00, 3 months 4 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV (Euronext Brussel: OXUR) ontvangt transparantiekennisgeving met betrekking tot aandelenbezit en kondigt ambitie aan om Europese farmaceutische onderaannemers te verwerven Transparantiekennisgeving Euronext Brussel Oxurion NV België Farmaceutische Onderaannemers
PRESS RELEASE published on 03/18/2026 at 18:00, 3 months 4 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a stake increase above the threshold. Oxurion specializes in acquiring pharmaceutical subcontractors Transparency Notification Oxurion NV Belgian Transparency Legislation Atlas Special Opportunities II Pharmaceutical Subcontractors
BRIEF published on 03/16/2026 at 18:05, 3 months 6 days ago Oxurion expands its capital following the conversion of bonds Ordinary Shares Convertible Bonds Capital Increase Atlas Oxurion
BRIEF published on 03/16/2026 at 18:05, 3 months 6 days ago Oxurion augmente ses actions avec droit de vote suite à la conversion Obligations Convertibles Augmentation De Capital Droit De Vote Oxurion Opportunités Spéciales Atlas
BRIEF published on 03/16/2026 at 18:05, 3 months 6 days ago Oxurion Increases Voting Shares Following Conversion Voting Rights Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
Published on 06/22/2026 at 21:05, 1 hour 47 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 3 hours 7 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 6 hours 54 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 7 hours 22 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 7 hours 52 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 21:07, 1 hour 44 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 2 hours 1 minute ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 2 hours 19 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 3 hours 24 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:54, 3 hours 57 minutes ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:00, 4 hours 52 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION
